Wuxi Hyatech Co

Wuxi Hyatech Co FCF/Debt

The Free Cash Flow to Debt Ratio of Wuxi Hyatech Co (688510.SS) as of Nov 2, 2026 is 26.28 %. In the previous year, Free Cash Flow to Debt Ratio was 6.69 % — a change of 292.88% (higher).

FCF/Debt

26.28 %

YoY

292.88%

Last updated:

Free Cash Flow to Debt Ratio of Wuxi Hyatech Co is 2025 26.28 % . Free Cash Flow to Debt Ratio of Wuxi Hyatech Co was 2024 6.69 % . It decreases by 292.88% higher compared to the previous year.

The Wuxi Hyatech Co FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
-242.51 CNY
Jan 1, 2019
-104.24 CNY
Jan 1, 2020
-58.93 CNY
Jan 1, 2021
-67.81 CNY
Jan 1, 2022
-154.21 CNY
Jan 1, 2023
-140.60 CNY
Jan 1, 2024
6.69 CNY
Jan 1, 2025
26.28 CNY
The Wuxi Hyatech Co FCF/Debt history
YEARFCF/DebtYoY
26.28 %+292.88%
6.69 %-104.76%
-140.60 %-8.83%
-154.21 %+127.41%
-67.81 %+15.07%
-58.93 %-43.47%
-104.24 %-57.02%
-242.51 %+562.92%
-36.58 %-68.83%
-117.37 %-44.73%
-212.34 %-17.15%
-256.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wuxi Hyatech Co Stock analysis

What does Wuxi Hyatech Co do? Wuxi Hyatech Co Ltd generates revenue through the research and development, manufacturing, and sales of key components for aero-engines and medical orthopedic implant forgings. The company produces high-performance components including aviation turbofan engine compressor blades, rotating parts, and structural parts, which are sold domestically and internationally. Its primary customers are aerospace manufacturers and medical device companies requiring specialized forgings for engine parts and orthopedic implants. The firm targets the aerospace and medical sectors with its focus on precision-engineered components for critical applications. The company's product portfolio includes aviation turbofan engine compressor blades, rotating parts, and structural parts, alongside medical orthopedic implant forgings. These products are distributed across domestic and overseas markets, serving both the Chinese aerospace industry and international medical device markets. Wuxi Hyatech's revenue streams are derived from direct sales of these specialized components to industrial and medical clients without third-party intermediaries. Wuxi Hyatech's business model centers on supplying high-precision components for aero-engines and medical orthopedic implants. The company's manufacturing capabilities enable it to produce critical parts for aircraft engines and orthopedic devices, with a focus on domestic and international industrial clients. Revenue is generated through the sale of these specialized forgings to aerospace and medical sectors, leveraging its R&D expertise in component production. Wuxi Hyatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wuxi Hyatech Co stock

Free Cash Flow to Debt Ratio of Wuxi Hyatech Co is 26.28 % in 2025.

Free Cash Flow to Debt Ratio of Wuxi Hyatech Co changed from 6.69 % to 26.28 %, representing a 292.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Wuxi Hyatech Co since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Wuxi Hyatech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Wuxi Hyatech Co

All Key Metrics — Wuxi Hyatech Co